Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNTE
3576
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $547K | ﹤0.01% |
230,753
+9,239
| +4% | +$21.9K |
|
|
CRON
3577
Cronos Group
CRON
$965M
| $545K | ﹤0.01% |
260,717
| – | – |
|
3578
Broadwind
BWEN
$49.5M
| $545K | ﹤0.01% |
196,605
+154
| +0.1% | +$427 |
|
3579
Southland Holdings
SLND
$228M
| $545K | ﹤0.01% |
105,510
+1,225
| +1% | +$6.32K |
|
3580
Alpha Teknova
TKNO
$214M
| $544K | ﹤0.01% |
145,880
+71,984
| +97% | +$269K |
|
|
OKUR
3581
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.7M
| $543K | ﹤0.01% |
33,954
+891
| +3% | +$14.3K |
|
|
CGAU
3582
Centerra Gold
CGAU
$1.81B
| $543K | ﹤0.01% |
90,867
+5,671
| +7% | +$33.9K |
|
3583
Perma-Pipe International
PPIH
$259M
| $542K | ﹤0.01% |
69,552
| – | – |
|
|
CYT
3584
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $541K | ﹤0.01% |
177,930
+14,393
| +9% | +$43.8K |
|
|
ADTH
3585
DELISTED
AdTheorent Holding Company, Inc. Common Stock
ADTH
| $541K | ﹤0.01% |
372,985
+21,323
| +6% | +$30.9K |
|
3586
ECARX Holdings
ECX
$630M
| $540K | ﹤0.01% |
170,906
+31,267
| +22% | +$98.8K |
|
3587
Hyperfine
HYPR
$104M
| $538K | ﹤0.01% |
480,253
| – | – |
|
3588
American Realty Investors
ARL
$274M
| $537K | ﹤0.01% |
30,829
| – | – |
|
3589
Rockwell Medical
RMTI
$56.5M
| $537K | ﹤0.01% |
283,923
+40,915
| +17% | +$77.3K |
|
|
KRON
3590
DELISTED
Kronos Bio
KRON
| $536K | ﹤0.01% |
428,522
+18,205
| +4% | +$22.8K |
|
3591
Galicia Financial Group
GGAL
$5.14B
| $534K | ﹤0.01% |
30,914
| – | – |
|
|
QXO
3592
QXO Inc
QXO
$14.3B
| $531K | ﹤0.01% |
3,882
+1,446
| +59% | +$198K |
|
|
BLEU
3593
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
| $531K | ﹤0.01% |
49,905
-228
| -0.5% | -$2.43K |
|
|
MGIC
3594
Magic Software Enterprises
MGIC
$1.01B
| $531K | ﹤0.01% |
54,798
+216
| +0.4% | +$2.09K |
|
3595
NewAmsterdam Pharma
NAMS
$2.94B
| $529K | ﹤0.01% |
47,324
+5,516
| +13% | +$61.6K |
|
3596
MPLX
MPLX
$51B
| $528K | ﹤0.01% |
14,384
+172
| +1% | +$6.32K |
|
3597
Direct Digital Holdings
DRCT
$9.3M
| $527K | ﹤0.01% |
35,428
+11,417
| +48% | +$170K |
|
3598
Gulf Island Fabrication
GIFI
$120M
| $527K | ﹤0.01% |
121,627
| – | – |
|
|
DMTK
3599
DELISTED
DermTech, Inc. Common Stock
DMTK
| $526K | ﹤0.01% |
300,274
+18,953
| +7% | +$33.2K |
|
3600
Wheels Up
UP
$1.46B
| $525K | ﹤0.01% |
152,873
-17,552
| -10% | -$60.2K |
|